Výsledky vyhledávání - "Angel, Cosme"

Akademický článek

Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.

Autor: Luis Bujanda, Cristina Sarasqueta, Angel Cosme, Elizabeth Hijona, José M Enríquez-Navascués, Carlos Placer, Eloisa Villarreal, Marta Herreros-Villanueva, María D Giraldez, Meritxell Gironella, Francesc Balaguer, Antoni Castells

Publikováno v: PLoS ONE, Vol 8, Iss 1, p e51810 (2013)

BACKGROUND: Colorectal cancer (CRC) is the second most common cause of death from cancer in both men and women in the majority of developed countries. Molecular tests of blood could potentially provide this ideal screening tool. AIM: Our objective wa

Externí odkaz: https://doaj.org/article/48ad09bada124e6abd0ac023f5fda14d

Zobrazit plný text záznamu

Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain

Autor: Estefania Carrasco-Garcia, Diana Rojas‐Rengifo, Jacobo Lizasoain, Angel Cosme, Esther Tamayo, María Fernández-Reyes, Luis Bujanda, Milagrosa Montes, Marta Alonso, Wolfgang Fischer

Publikováno v: European journal of clinical investigation. 49(8)

Background Helicobacter pylori infection is associated with chronic gastritis, ulcers and gastric cancer. Antimicrobial resistance has increased worldwide affecting the efficacy of current treatments. Most guidelines recommend implementation of regio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4869db604c0a5708d56153f7df294b62
https://pubmed.ncbi.nlm.nih.gov/31192451

Zobrazit plný text záznamu

Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies

Autor: Horacio Alonso Galán, María Fernández-Reyes Silvestre, Milagrosa Montes Ros, Luis Bujanda, Jacobo Lizasoain, Angel Cosme, Silvia Torrente Iranzo

Publikováno v: Helicobacter. 24(1)

Background Antibiotic resistance is the main cause for Helicobacter pylori therapy failure. Frequently, empirical regimens have been recommended in patients with various H. pylori eradication failures. In patients with H. pylori-resistant to various

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb70bdb3c13eb16545ec5139dca2f00f
https://pubmed.ncbi.nlm.nih.gov/30460730

Zobrazit plný text záznamu

Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication ofHelicobacter pyloriin a Region with High Rate of Clarithromycin Resistance

Autor: Usua Mendarte, Milagrosa Montes, Angel Cosme, Cristina Saraqueta, Esther Tamayo, Horacio Alonso, Jacobo Lizasoan, Maider Martos, Luis Bujanda, María Fernández-Reyes

Publikováno v: Helicobacter. 21:29-34

Background Nonbismuth quadruple (concomitant) regimen is recommended for first-line empirical Helicobacter pylori (HP) eradication treatment when clarithromycin resistance is more than 15–20%. Our objective was to evaluate the efficacy and tolerabi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce6de0ef1b896a4638de4ae984d156f9
https://doi.org/10.1111/hel.12231

Zobrazit plný text záznamu

Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions

Autor: Angel Cosme, Begoña Ibarra, Cristina Sarasqueta, Yolanda Salicio, Maider Martos, Usua Mendarte, María Fernández-Reyes, Luis Bujanda

Publikováno v: European Journal of Gastroenterology & Hepatology. 26:1380-1384

OBJECTIVE Resistance to antibiotics is the major cause of treatment failure of Helicobacter pylori (HP) infection. The culture-guided triple therapy (chosen on the basis of a preliminary in-vitro susceptibility test) might help to increase treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2935db40eb17ddddb381bc8f63e0b671
https://doi.org/10.1097/meg.0000000000000197

Zobrazit plný text záznamu

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

Autor: B. Sacristán, Manuel Castro-Fernandez, Alicia Algaba, Ángeles Pérez-Aisa, Ines Modolell, Luis Rodrigo, Jesus Barrio, Rosario Anton, M. Gonzalez-Barcenas, Angel Cosme, Adrian G. McNicholl, Yamal Harb, Javier P. Gisbert, Javier Molina-Infante, Fernando Bermejo, Miguel Fernández-Bermejo, Alicia C Marin

Publikováno v: Digestive Diseases and Sciences. 59:383-389

Helicobacter pylori eradication therapy with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin fails in >20 % of cases. A rescue therapy with PPI–amoxicillin–levofloxacin still fails in >20 % of patients. To evaluate the efficacy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc3533ea5995ea09f31b99a3ce7b8c6
https://doi.org/10.1007/s10620-013-2900-x

Zobrazit plný text záznamu

Effect of Aspirin and Antiplatelet Drugs on the Outcome of the Fecal Immunochemical Test

Autor: Angel Lanas, Vicent Hernandez, Cristina Sarasqueta, Antoni Castells, Luis Bujanda, Enrique Quintero, Angel Cosme, Xavier Bessa, Dolores Salas, Teresa Perez-Fernández, Rodrigo Jover, Joaquín Cubiella, Fernando Carballo, Juan Diego Morillas, Montserrat Andreu

Publikováno v: Mayo Clinic Proceedings. 88:683-689

Objective To evaluate the effect of aspirin and nonaspirin antiplatelet agents (NAAAs) on the performance of the fecal immunochemical test (FIT). Participants and Methods We performed a post hoc analysis of results from a clinical trial that involved

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2e31acbd6bf66a6ad30380558efc5e
https://doi.org/10.1016/j.mayocp.2013.04.016

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání